Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer

Author:

São José Celina,Garcia-Pelaez José,Ferreira Marta,Arrieta Oscar,André Ana,Martins Nelson,Solís Samantha,Martínez-Benítez Braulio,Ordóñez-Sánchez María Luisa,Rodríguez-Torres Maribel,Sommer Anna K.,te Paske Iris B. A. W.,Caldas Carlos,Tischkowitz Marc,Tusié Maria Teresa,Aretz Stefan,Capella Gabriel,Castedo Sérgio,de Voer Richarda M.,Evans Gareth,Fernandes Susana,Garcia-Pelaez José,Garrido Luzia,Holinski-Feder Elke,Hoogerbrugge Nicoline,Huntsman David,Jahn Arne,Kets C. Marleen,Laner Andreas,Ligtenberg Marjolijn,Meinhardt Andrea,Mensenkamp Arjen,Oliveira CarlaORCID,Peters Sophia,Quintana Isabel,Schröck Evelin,Sommer Anna,Spier Isabel,Spruijt Liesbeth,Steinke-Lange Verena,Paske Iris te,Tischkowitz Marc,Valle Laura,van der Post Rachel,van Herwaarden Yasmijn,van Zelst-Stams Wendy,William Doreen,Hoogerbrugge Nicoline,Demidov German,de Voer Richarda M.,Laurie Steve,Oliveira CarlaORCID,

Abstract

Abstract Background Germline CDH1 pathogenic or likely pathogenic variants cause hereditary diffuse gastric cancer (HDGC). Once a genetic cause is identified, stomachs’ and breasts’ surveillance and/or prophylactic surgery is offered to asymptomatic CDH1 carriers, which is life-saving. Herein, we characterized an inherited mechanism responsible for extremely early-onset gastric cancer and atypical HDGC high penetrance. Methods Whole-exome sequencing (WES) re-analysis was performed in an unsolved HDGC family. Accessible chromatin and CDH1 promoter interactors were evaluated in normal stomach by ATAC-seq and 4C-seq, and functional analysis was performed using CRISPR-Cas9, RNA-seq and pathway analysis. Results We identified a germline heterozygous 23 Kb CDH1-TANGO6 deletion in a family with eight diffuse gastric cancers, six before age 30. Atypical HDGC high penetrance and young cancer-onset argued towards a role for the deleted region downstream of CDH1, which we proved to present accessible chromatin, and CDH1 promoter interactors in normal stomach. CRISPR-Cas9 edited cells mimicking the CDH1-TANGO6 deletion display the strongest CDH1 mRNA downregulation, more impacted adhesion-associated, type-I interferon immune-associated and oncogenic signalling pathways, compared to wild-type or CDH1-deleted cells. This finding solved an 18-year family odyssey and engaged carrier family members in a cancer prevention pathway of care. Conclusion In this work, we demonstrated that regulatory elements lying down-stream of CDH1 are part of a chromatin network that control CDH1 expression and influence cell transcriptome and associated signalling pathways, likely explaining high disease penetrance and very young cancer-onset. This study highlights the importance of incorporating scientific–technological updates and clinical guidelines in routine diagnosis, given their impact in timely genetic diagnosis and disease prevention. Graphical abstract

Funder

Horizon 2020

Fundação para a Ciência e a Tecnologia

NIHR Cambridge Biomedical Research Centre

Universidade do Porto

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3